Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis
- PMID: 8751344
- DOI: 10.1159/000310655
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis
Abstract
The effectiveness of passively transferred antibodies directed against the secretory form of herpes simplex virus type 1 (HSV-1) glycoprotein B (gB1-s) was tested in a rabbit model of ocular HSV-1 infection. The animals were passively immunized through the intramuscular injection of a homologous polyclonal anti-gB1-s antiserum at different times from the viral ocular challenge (i.e. at -24, 0, +24 and +48 h from infection). The effects observed in this trial were compared with those obtained in an active immunization trial, in which the animals were vaccinated with gB1-s before the ocular infection with HSV-1 (large variant). The results have shown that passive immunization appears quite effective in prophylactic utilization, whereas it is less effective when performed at 24 or 48 h after inoculation. By contrast, active immunization of rabbits proved to be highly effective both in preventing the development of fatal encephalitis and in reducing the severity of corneal lesions.
Similar articles
-
A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.J Virol. 2016 May 12;90(11):5514-5529. doi: 10.1128/JVI.00517-16. Print 2016 Jun 1. J Virol. 2016. PMID: 27030264 Free PMC article.
-
Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.Invest Ophthalmol Vis Sci. 1993 Jul;34(8):2460-8. Invest Ophthalmol Vis Sci. 1993. PMID: 8392037
-
Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins.Invest Ophthalmol Vis Sci. 1995 Jun;36(7):1352-60. Invest Ophthalmol Vis Sci. 1995. PMID: 7775113
-
Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.J Virol. 2015 Jul;89(13):6619-32. doi: 10.1128/JVI.00788-15. J Virol. 2015. PMID: 25878105 Free PMC article.
-
Herpes simplex virus type 1 infection of the cornea.Dev Ophthalmol. 1999;30:141-66. doi: 10.1159/000060741. Dev Ophthalmol. 1999. PMID: 10627922 Review. No abstract available.
Cited by
-
Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling.J Virol. 2012 Apr;86(8):4328-39. doi: 10.1128/JVI.05194-11. Epub 2012 Feb 8. J Virol. 2012. PMID: 22318154 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical